STOCK COMMENTS / EPS CHANGES
Blackstone (BX) estimates, price target were increased at Jefferies. Estimates were raised through 2014. Outlook for growth and fee generation is the best it's been in years, said Jefferies. Buy rating and new $30 price target.
Eli Lilly (LLY) numbers were reduced at Guggenheim. Shares are now seen reaching $61. Estimates were also cut, as the company's breast cancer treatment failed in clinical trials. Outperform rating.
(MKC) estimates, price target were lowered at Jefferies. Shares are now seen reaching $76. Estimates were also cut, given the company's new guidance, Jefferies said. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV